Skip to main content

UBS Group AG

Position in SOLV — Solventum Corp

CIK 1610520 ZURICH, V8

Position in SOLV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$41,103,821
-$229,379 QoQ
Shares Held
532,778
-15.8% QoQ
Ownership
0.313%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 875 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in SOLV Over Time

Shares Held

Position Value (USD)

Derivatives in SOLV

reported options exposure · as of Dec 31, 2025
CallValue
$253,568
CallShares
3,200
PutValue
$253,568
PutShares
3,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Jun 30, 2026

UBS Group AG holds $3,388,769,855 across 51 Medical Instruments & Supplies names. SOLV ranks #14 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SOLV

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,103,821 532,778
2026-03-31 $41,333,200 632,974
2025-12-31 $253,568 3,200
2025-12-31 $253,568 3,200
2025-12-31 $59,261,375 747,872
2025-09-30 $963,600 13,200
2025-09-30 $43,320,828 593,436
2025-09-30 $233,600 3,200
2025-06-30 $46,632,194 614,876
2025-03-31 $43,983,739 578,429
2024-12-31 $32,462,211 491,405
2024-09-30 $29,316,142 420,484
2024-06-30 $20,882,730 394,908